Sonic Healthcare stock

SHL · ASX · AUD

Compare Sonic Healthcare
$20.16Change from previous close: +0.45%Absolute change: +$0.09

Close · November 18, 2026

Price history

−3.49% over the period

1 year: from $20.89 (November 18, 2025) to $20.16 (November 18, 2026), −3.49%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 18, 2026$20.16
October 30, 2026$19.57
September 30, 2026$18.99
August 31, 2026$19.59
July 31, 2026$21.86
June 30, 2026$20.81
May 29, 2026$19.52
April 30, 2026$19.77
March 31, 2026$20.45
February 27, 2026$23.83
January 30, 2026$22.95
December 31, 2025$22.61
November 28, 2025$23.33
November 18, 2025$20.89

At a glance

  • The company

    Provider of laboratory medicine, radiology, and primary care medical services across Australia, the United States, Germany, and internationally

  • Latest results

    Quarter to June 30, 2026 · EPS $0.70 (estimate $1.41)

TickerLandia's take on Sonic Healthcare

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$18.11
52-wk high$24.27

−16.93% from the 52-week high

Analysts · 16 analysts

Average target$22.12+9.71% vs. price

Buy 3 · Hold 10 · Sell 3 · Hold

TickerLandia Fingerprint: Sonic Healthcare

Compared with similar companies: very low price and very high dividend.

Financials and price compared with 27 companies in the diagnostics & research industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Sonic Healthcare is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2026), Sonic Healthcare's P/E today is 16.4, below the median of its last 10 fiscal years (23.0; between 10.9 and 27.5 from 2017 to 2026). Sonic Healthcare's P/E (trailing 12 months): 16.2, −48% against the median of a group of 11 similar companies (31.0).

P/E compared with its history

Compared with 11 similar companies

Sonic Healthcare's metrics compared with similar companies
MetricSonic HealthcarePosition in the groupBand
P/E (trailing 12 months)16.2Low
Forward P/E16.3Low
Operating margin9.3%Low
ROE7.5%Middle
Debt/equity0.69High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Sonic Healthcare. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$5.42B

Latest quarter · Q2 2026

Net income

$345.81M

Latest quarter · Q2 2026

Quarterly net margin

6.4%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$9.82B
P/E
16.2
EPS
$1.23
Volume
1.28M
Daily trading
€17.46M
Dividend yield
5.36%
Last ex-dividend on September 2, 2026

How Sonic Healthcare is changing

All results
  • Revenue grew 4.4% a year on average over the last 5 years

  • Operating margin fell from 12.5% to 9.3%

  • Profits turn into cash: free cash flow equal to 143% of net income

Returns

Sonic Healthcare returns with dividends

$1,000 invested in Sonic Healthcare 5 years ago, on November 18, 2021, would be worth $617 today with dividends reinvested: −38.27% in total, −9.20% per year. On price alone it would be $507 (−49.28%).

PeriodSonic HealthcareS&P/ASX 200$1,000 becomes
1 month+8.80%+0.42%$1,088
6 months+9.62%+4.44%$1,096
Year to date−10.84%+1.94%$892
1 year+1.70%+4.89%$1,017
3 years−20.92%+25.85%$791
5 years−38.27%+20.38%$617
10 years+28.76%+65.75%$1,288

Over the last 6 months it has done better than 31% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment

The chart in detail

Sonic Healthcare: technical analysis

Sonic Healthcare shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 56.8% below its highest close since January 1, 1990 ($46.71, December 30, 2021).

Trend
No clear trend
RSI (14 sessions)
66
Between 30 and 70
vs 200-session average
−0.84%

Support and resistance

Price areas where Sonic Healthcare has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$21.86+8.43%2 touches, last on July 8, 2026
  2. Resistance$20.90+3.67%2 touches, last on April 20, 2026
  3. Resistance$20.67+2.52%4 touches, last on July 24, 2026
  4. Last price$20.16
  5. Support$19.67−2.44%4 touches, last on September 17, 2026
  6. Support$18.88−6.35%2 touches, last on September 11, 2026
  7. Support$18.42−8.65%3 touches, last on October 2, 2026

Volatility and risk

Over the last year it has moved less than the S&P/ASX 200.

Beta (1 year) vs S&P/ASX 200
0.59
Volatility (60 sessions, annualised)
20.0%
Largest fall in the last year
−23.01%

In session, November 18, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Sonic Healthcare: seasonality

Average monthly price change over 37 years

+1.5%Jan+0.4%Feb+1.4%Mar+1.3%Apr+1.7%May+3.0%Jun+1.1%Jul+5.1%Aug−0.5%Sep−0.2%Oct+4.3%Nov+2.1%Dec

Over the last 37 years, the strongest month for Sonic Healthcare has been August: +5.13% on average, positive in 21 years out of 37. The weakest has been September: −0.47% on average, positive in 15 years out of 37. November, the current month, has been positive in 27 years out of 36 (+4.29% on average).

Show chart data
MonthAverageMedianPositive years
January+1.51%+1.39%20 of 36
February+0.36%0.00%18 of 37
March+1.40%0.00%17 of 37
April+1.30%+0.72%19 of 37
May+1.72%+0.06%19 of 37
June+2.98%+4.10%31 of 37
July+1.09%0.00%17 of 37
August+5.13%+0.07%21 of 37
September−0.47%−1.50%15 of 37
October−0.18%−0.23%17 of 37
November+4.29%+3.13%27 of 36
December+2.11%−0.06%16 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Sonic Healthcare and its competitors

With revenue of AUD 10.9 billion in the fiscal year ended June 2026, the group runs laboratory and imaging services, with pathology testing ranging from haematology and genetics to toxicology and prenatal testing. Its radiology operations cover MRI, CT, ultrasound, mammography and PET CT, while its primary care activities include general practice clinics, occupational health services and skin cancer clinics. The group also offers clinical trial services and chronic disease management programmes, with operations in Australia, the United States and Germany as well as other international markets.

Headquarters
Sydney, Australia
Employees
47,000
Founded
1934
Chief executive
James Newcombe
Sonic Healthcare and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Sonic HealthcareSHL$6.61B9.3%16.2+9.62%
WuXi XDC Cayman2268$10.89B28.1%52.7+21.16%
WuXi AppTec603259$66.5B44.8%16.1+38.20%
DiaSorinDIA$4.56B22.3%31.0+16.24%
QiagenQIA$10.3B26.7%27.3+58.79%
bioMérieuxBIM$11.7B16.0%23.2+26.52%

Same industry or related industries, similar size. Compare Sonic Healthcare with its competitors · Full profile